Allotment of 101825 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan 2022

Corporate Office: Plot No. 412-415, Nimai Tower, 3rd Floor, Phase-IV, Udyog Vihar, Sector-18, Gurugram -122015, Haryana (India) Ph.: +91 124 4406710; E-mail: info@jagsonpal.com; Website: www.jagsonpal.com CIN. : L74899DL1978PLC009181 September 30, 2026 The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Mumbai-400 001 Bandra Kurla Complex, Bandra (E) Mumbai – 400 Scrip Code: 507789 051 Symbol: JAGSNPHARM Subject: Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 (“JPL ESOP 2022”) Dear Sir/ Madam, Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are pleased to inform you that the Nomination and Remuneration Committee has issued and allotted 1,01,825 Equity Shares of Rs. 2/- each under JPL ESOP 2022, to the eligible employees of the Company, upon exercise of vested options. These shares shall rank Pari-passu with the existing equity shares of the Company, in all respects. Consequent to the above allotment, the paid-up share capital of the Company has increased from Rs. 13,19,14,840 (constituting of 6,59,57,420 equity shares of Rs. 2/- each) to Rs. 13,21,18,490 (constituting of 6,60,59,245 equity shares of Rs. 2/- each). Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, is attached herewith. We request you to take the above on record. Thanking you, For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & Compliance officer Regd. Office: Innov8, 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020 (India) Mumbai Office: 13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070 Corporate Office: Plot No. 412-415, Nimai Tower, 3rd Floor, Phase-IV, Udyog Vihar, Sector-18, Gurugram -122015, Haryana (India) Ph.: +91 124 4406710; E-mail: info@jagsonpal.com; Website: www.jagsonpal.com CIN. : L74899DL1978PLC009181 Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 Sr. Particulars 1. Company name and address of Registered Jagsonpal Pharmaceuticals Limited and Office: Registered Office- Innov8, 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi- 110020 2. Name of the recognized Stock Exchanges on BSE Limited and National Stock Exchange of which the company's shares are listed: India Limited 3. Filing date of the statement referred in July 26, 2022 - BSE Regulation 10(b) of the SEBI (Share Based July 27, 2022 - NSE Employee Benefits) Regulations, 2021 with Stock Exchange: 4. Filing Number, if any: NA 5. Title of the Scheme pursuant to which shares are Jagsonpal Pharmaceuticals Limited Employee issued, if any: Stock Option Plan, 2022 6. Kind of security to be listed: Equity Shares 7. Par value of the shares Rs. 2/- 8. Date of issue of shares September 30, 2026 9. Number of shares issued: 1,01,825 10. Share Certificate No., if applicable: NA 11. Distinctive number of the share, if applicable: 6,75,57,421 to 6,76,59,245 12. ISIN Number of the shares if issued in Demat: INE048B01035 13. Exercise price per share: Rs. 94.00/- for 1,00,000 Equity Shares Rs. 115.60/- for 1,825 Equity Shares 14. Premium per share: Rs. 92.00/- for 1,00,000 Equity Shares Rs. 113.60/- for 1,825 Equity Shares 15. Total Issued shares after this issue: 6,60,59,245 16. Total Issued share capital after this issue: Rs. 13,21,18,490 17. Details of any lock-in on the shares: NA 18. Date of expiry of lock-in: NA 19. Whether shares identical in all respects to Yes, the shares rank pari passu with the existing existing shares if not, when will they become shares identical? 20. Details of listing fees, if payable: NA For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & compliance officer Regd. Office: Innov8, 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020 (India) Mumbai Office: 13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070